Galactofuranose metabolism: A potential target for antimicrobial chemotherapy

Cellular and Molecular Life Sciences

Volumn 60, Issue 2, 2003, Pages 259-266

  Pedersen, L L ^a   Turco, S J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Arabinogalactan; Galactofuranose; Lipophosphoglycan; Microorganisms; Pathogenic microbes

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ARABINOGALACTAN; ETHAMBUTOL; ETHIONAMIDE; GALACTOFURANOSE; GALACTOSE; GLYCOCONJUGATE; ISONIAZID; MYCOLIC ACID; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BIOCHEMISTRY; CARBOHYDRATE METABOLISM; CHEMOTHERAPY; GENETIC ANALYSIS; METABOLIC REGULATION; MOLECULAR STABILITY; NONHUMAN; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GALACTOSE; GLYCOCONJUGATES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEISHMANIA;

EID: 0037301077     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180300021     Document Type: Review

References (84)

1. The crisis in antibiotic resistance
2. Cohen M. L. (1992) Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257: 1050-1055
3. Bloom B. R. and Murray C. J. (1992) Tuberculosis: commentary on a reemergent killer. Science 257: 1055-1064
4. Desjeux D. P. (2002) World Health Organization: programme for the surveillance and control of Leishmaniasis. Accessed 4/11/02 at http://www.who.int/emc/diseases/leish/index.html
5. Herwaldt B. L. (1999) Leishmaniasis. Lancet 354: 1191-1199
6. Sereno D., Guilvard E., Maquaire S., Cavaleyra M., Holzmuller P., Ouaissi A. et al. (2001) Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas. Acta Trop. 80: 195-205
7. De Lederkremer R. M. and Colli W. (1995) Galactofuranose-containing glycoconjugates in trypanosomatids. Glycobiology 5: 547-552
8. Jann B., Shashkov A. S., Kochanowski H. and Jann K. (1994) Structure of the O16 polysaccharide from Escherichia coli O16:K1: an NMR investigation. Carbohydr. Res. 264: 305-311
9. Kol O., Wieruszeski J. M., Strecker G., Montreuil J., Fournet B., Zalisz R. et al. (1991) Structure of the O-specific polysaccharide chain from Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. Carbohydr. Res. 217: 117-125
10. Dmitriev B. A., Lvov V. L. and Kochetkov N. K. (1977) Complete structure of the repeating unit of the O-specific polysaccharide chain of Shigella dysenteriae type 3 lipopolysaccharide. Carbohydr. Res. 56: 207-209
11. Altman E., Brisson J. R. and Perry M. B. (1988) Structure of the O-antigen polysaccharide of Haemophilus pleuropneumoniae serotype 3 (ATCC 27090) lipopolysaccharide. Carbohydr. Res. 1988. 179: 245-258
12. Perry M. B. (1990) Structural analysis of the lipopolysaccharide of Actinobacillus (Haemophilus) pleuropneumoniae serotype 10. Biochem Cell Biol. 68: 808-810
13. Stevenson G., Neal B., Liu D., Hobbs M., Packer N. H., Batley M. et al. (1994) Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J. Bacteriol. 176: 4144-4156
14. Sarvas M. and Nikaido H. (1971) Biosynthesis of T1 antigen in Salmonella: origin of D-galactofuranose and D-ribofuranose residues. J. Bacteriol. 105: 1063-1072
15. Abeygunawardana C., Bush C. A., Tjoa S. S., Fennessey P. V. and McNeil M. R. (1989) The complete structure of the capsular polysaccharide from Streptococcus sanguis 34. Carbohydr. Res. 191: 279-293
16. Abeygunawardana C., Bush C. A. and Cisar J. O. (1990) Complete structure of the polysaccharide from Streptococcus sanguis J22. Biochemistry 29: 234-248
17. Abeygunawardana C., Bush C. A. and Cisar J. O. (1991) Complete structure of the cell surface polysaccharide of Streptococcus oralis C104: a 600-MHz NMR study. Biochemistry 30: 8568-8577
18. Abeygunawardana C., Bush C. A. and Cisar J. O. (1991) Complete structure of the cell surface polysaccharide of Streptococcus oralis ATCC 10557: a receptor for lectin-mediated inter-bacterial adherence. Biochemistry 30: 6528-6540
19. Bax A., Summers M. F., Egan W., Guirgis N., Schneerson R., Robbins J. B. et al. (1988) Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides. Carbohydr. Res. 173: 53-64
20. Besra G. S., Khoo K. H., McNeil M. R., Dell A., Morris H. R., and Brennan P. J. (1995) A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1 H nuclear magnetic resonance spectroscopy. Biochemistry 34: 4257-4266
21. De Arruda M.V., Colli W. and Zingales B. (1989)Terminal β-D-galactofuranosyl epitopes recognized by antibodies that inhibit Trypanosoma cruzi internalization into mammalian cells. Eur. J. Biochem 182: 413-421
22. Previato J. O., Gorin P. A., Mazurek M., Xavier M. T., Fournet B., Wieruszesk J. M. et al. (1990) Primary structure of the oligosaccharide chain of lipopeptidophosphoglycan of epimastigote forms of Trypanosoma cruzi. J. Biol. Chem. 265: 2518-2526
23. Turco S. J., Orlandi P. A. Jr, Homans S. W., Ferguson M. A., Dwek R.A. and Rademacher T. W. (1989) Structure of the phosphosaccharide-inositol core of the Leishmania donovani lipophosphoglycan. J. Biol. Chem. 264: 6711-6715
24. McConville M. J., Homans S. W., Thomas-Oates J. E., Dell A. and Bacic A. (1990) Structures of the glycoinositolphospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids. J. Biol. Chem. 265: 7385-7394
25. Ilg T., Etges R., Overath P., McConville M. J., Thomas-Oates J., Thomas J. et al. (1992) Structure of Leishmania mexicana lipophosphoglycan. J. Biol. Chem. 267: 6834-6840
26. Unkefer C. J. and Gander J. E. (1979) The 5-O-beta-D-galactofuranosyl-containing glycopeptide from Penicillium charlesii. Carbon 13 nuclear magnetic resonance studies. J. Biol. Chem. 254: 12131-12135
27. Parra E., Jimenez-Barbero J., Bernabe M., Leal J. A., Prieto A. and Gomez-Miranda B. (1994) Structural investigation of two cell-wall polysaccharides of Penicillium expansum strains. Carbohydr. Res. 257: 239-248
28. Takayanagi T., Kimura A., Chiba S. and Ajisaka K. (1994) Novel structures of N-linked high-mannose type oligosaccharides containing α-D-galactofuranosyl linkages in Aspergillus niger α-D-glucosidase. Carbohydr. Res. 256: 149-158
29. Nakajima T., Yoshida M., Nakamura M., Hiura N. and Matsuda K. (1984) Structure of the cell wall proteogalactomannan from Neurospora crassa. II. Structural analysis of the polysaccharide part. J. Biochem. 96: 1013-1020
30. Barr K., Laine R. A. and Lester R. L. (1984) Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry 23: 5589-5596
31. Levery S. B., Toledo M. S., Straus A. H. and Takahashi H. K. (1998) Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant beta-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. Biochemistry 37: 8764-8775
32. Golgher D. B., Colli W., Souto-Padron T. and Zingales B. (1993) Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol. 60: 249-264
33. Trejo A. G., Chittenden G. J., Buchanan J. G. and Baddiley J. (1970) Uridine diphosphate alpha-D-galactofuranose, an intermediate in the biosynthesis of galactofuranosyl residues. Biochem J. 117: 637-639
34. Nikaido H. and Sarvas M. (1971) Biosynthesis of TI antigen in salmonella: biosynthesis in a cell-free system. J. Bacteriol. 105(3): 1073-1082
35. Huang C. and Turco S. J. (1993) Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani. J. Biol. Chem. 268: 24060-24066
36. Weston A., Stern R. J., Lee R. E., Nassau P. M., Monsey D., Martin S. L. et al. (1998) Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues. Tuber. Lung Dis. 78: 123-131
37. Nassau P. M., Martin S. L., Brown R. E., Weston A., Monsey D., McNeil M. R. et al. (1996) Galactofuranose biosynthesis in Escherichia coli K-12: Identification and cloning of UDP-galactopyranose mutase. J. Bacteriol. 178: 1047-1052
38. Koplin R., Brisson J. R. and Whitfield C. (1997) UDP-galactofuranose precursor required for formation of the lipopolysaccharide O antigen of Klebsiella pneumoniae serotype O1 is synthesized by the product of the rfbDKPO1 gene. J. Biol. Chem. 272: 4121-4128
39. Guan S., Clarke A. J. and Whitfield C. (2001) Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae. J. Bacteriol. 183: 3318-3327
40. Pan F., Jackson M., Ma Y. and McNeil M. (2001) Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J. Bacteriol. 183: 3991-3998
41. Kremer L., Dover L. G., Morehouse C., Hitchin P., Everett M., Morris H. R. et al. (2001) Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase. J. Biol. Chem. 276: 26430-26440
42. Whitfield C. (1995) Biosynthesis of lipopolysaccharide O antigens. Trends Microbiol. 3: 178-185
43. Heine H., Rietschel E. T. and Ulmer A. J. (2001) The biology of endotoxin. Mol. Biotechnol. 19: 279-296
44. Barry C. E. 3rd (1997) New horizons in the treatment of tuberculosis. Biochem. Pharmacol. 54: 1165-1172
45. Daffe M., Brennan P. J. and McNeil M. (1990) Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses. J. Biol. Chem. 265: 6734-6743
46. McNeil M., Daffe M. and Brennan P. J. (1991) Location of the mycolyl ester substituents in the cell walls of mycobacteria. J. Biol. Chem. 266: 13217-13223
47. McNeil M., Daffe M. and Brennan P. J. (1990) Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls. J. Biol. Chem. 265: 18200-18206
48. McNeil M., Besra G. S. and Brennan P. J. (1996) Chemistry of the mycobacterial cell wall. In: Tuberculosis, pp. 171-186, Rom W. N. and Garay S. M. (eds), Little, Brown, Boston
49. Takayama K. and Kilbum J. O. (1989) Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33: 1493-1499
50. Turco S. J. and Descoteaux A. (1992) The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46: 65-94
51. Descoteaux A. and Turco S. J. (1999) Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta Mol. Basis Dis. 1455: 341-352
52. McConville M. J. and Homans S. W. (1992) Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major. J. Biol. Chem. 267: 5855-5861
53. Sacks D. L. (1989) Metacyclogenesis in Leishmania promastigotes (1989) Exp. Parasitol. 69: 100-103
54. Puentes S. M., Da Silva R. P., Sacks D. L., Hammer C. H. and Joiner K. A. (1990) Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol. 145: 4311-4316
55. Puentes S. M., Sacks D. L., da Silva R. P. and Joiner K. A. (1988) Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J. Exp. Med. 167: 887-902
56. Beverley S. M. and Turco S. J. (1998) Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 6: 35-40
57. Desjardins M. and Descoteaux A. (1997) Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185: 2061-2068
58. Guha-Niyogi A., Sullivan D. R. and Turco S. J. (2001) Glycoconjugate structures of parasitic protozoa. Glycobiology 11: 45R-59R
59. Zhang Q. and Liu H. (2000) Studies of UDP-galactopyranose mutase from Escherichia coli: An unusual role of reduced FAD in its catalysis. J. Am. Chem. Soc. 122: 9065-9070
60. Zhang Q. and Liu H. (2001) Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes. J. Am. Chem. Soc. 123: 6756-6766
61. McMahon S. A., Leonard G. A., Buchanan L. V., Giraud M. F. and Naismith J. H. (1999) Initiating a crystallographic study of UDP-galactopyranose mutase from Escherichia coli. Erratum. Acta Crystallogr. D Biol. Crystallogr. 55: 1108
62. Sanders D. A., McMahon S. A., Leonard G. L. and Naismith J. H. (2001) Molecular placement of experimental electron density: a case study on UDP-galactopyranose mutase. Acta Crystallogr. D Biol Crystallogr. 57 (Pt 10): 1415-1420
63. Sanders D. A., Staines A. G., McMahon S. A., McNeil M. R., Whitfield C. and Naismith J. H. (2001) UDP-galactopyranose mutase has a novel structure and mechanism. Nat. Struct. Biol. 8: 858-863
64. Barlow J. N. and Blanchard J. S. (2000) Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase. Carbohydr. Res. 328: 473-480
65. Reeves R., Hobbs M., Valvano M. A., Skurnik M., Whitfield C., Coplin D. et al. (1996) Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 4: 495-503
66. Barlow J. N., Girvin M. E. and Blanchard J. S. (1999) Positional isotope exchange catalyzed by UDP-galactopyranose mutase. J. Am. Chem. Soc. 121: 6968-6969
67. Clarke B. R., Bronner D., Keenleyside W. J., Severn W. B., Richards J. C. and Whitfield C. (1995) Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1. J. Bacteriol. 177: 5411-5418
68. Ramaswamy S. and Musser J. M. (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79: 3-29
69. Quemard A., Lacave C. and Laneelle G. (1991) Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob. Agents Chemother. 35: 1035-1039
70. Baulard A. R., Betts J. C., Engohang-Ndong J., Quan S, McAdam R. A., Brennan J. et al. (2000) Activation of the pro-drug ethionamide is regulated in mycobacteria. J. Biol. Chem. 275: 28326-28331
71. McNeil M., Wallner S. J., Hunter S. W. and Brennan J. (1987) Demonstration that the galactosyl and arabinosyl residues in the cell-wall arabinogalactan of Mycobacterium leprae and Mycobacterium tuberculosis are furanoid. Carbohydr. Res. 166: 299-308
72. Mikusova K., Yagi T., Stern R., McNeil M. R., Besra G. S., Crick D. C. et al. (2000) Biosynthesis of the galactan component of the mycobacterial cell wall. J. Biol. Chem. 275: 33890-33897
73. Ilg T. (2001) Lipophosphoglycan of the protozoan parasite Leishmania: stage- and species-specific importance for colonization of the sandfly vector, transmission and virulence to mammals. Med. Microbiol. Immunol. 190: 13-17
74. McConville M. J. and Ferguson M. A. J. (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294: 305-324
75. Sacks D. and Kamhawi S. (2001) Molecular aspects of parasite-vector and vector-host interactions in Leishmaniasis. Annu. Rev. Microbiol. 55: 453-483
76. Sacks D. L., Saraiva E. M., Rowton E., Turco S. J. and Pimenta P. F. (1994) The role of the lipophosphoglycan of Leishmania in vector competence. Parasitology 108 Suppl.: S55-S62
77. King D. L. and Turco S. J. (1988) A ricin agglutinin-resistant clone of Leishmania donovani. Mol. Biochem. Parasitol. 28: 285-294
78. Elhay M., Kelleher M., Bacic A., McConville M. J., Tolson D. L., Pearson T. W. et al. (1990) Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major. Mol. Biochem. Parasitol. 40: 255-268
79. McNeely T. B. and Turco S. J. (1990) Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani with human monocytes. J. Immunol. 144: 2745-2750
80. McNeely T. B., Tolson D. L., Pearson T. W. and Turco S. J. (1990) Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies. Glycobiology 1: 63-69
81. Ryan K. A., Garraway L. A., Descoteaux A., Turco S. J. and Beverley S. M. (1993) Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc. Natl. Acad. Sci. USA 90: 8609-8613
82. Ilg T. (2000) Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J. 19: 1953-1962
83. Spath G. F., Epstein L., Leader B., Singer S. M., Avila H. A., Turco S. J. et al. (2000) Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 97: 9258-9263
84. Sacks D. L., Modi G., Rowton E., Spath G., Epstein L., Turco S. J. et al. (2000) The role of phosphoglycans in Leishmaniasand fly interactions. Proc. Natl. Acad. Sci. USA 97: 406-411